Peripheral effects of opioid drugs on capsaicin-sensitive neurones of the guinea-pig bronchus and rabbit ear
- 31 August 1987
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 336 (3) , 316-320
- https://doi.org/10.1007/bf00172684
Abstract
The effect of a potent opioid agonist, [d-Met2, Pro5]-enkephalinamide was investigated on two responses involving capsaicin-sensitive afferent neurones, namely, atropine-resistant contractions of the guinea-pig bronchus evoked by electrical field stimulation and the nociceptor stimulation to intraarterial injections of acetylcholine or capsaicin into the vascularly isolated rabbit ear. The hypotheses to be tested were whether (a) opioid receptor activation may inhibit mediator release from primary afferent neurones and (b) the opioid could exert an analgesic effect at a peripheral site of action. Non-cholinergic contractions of the guinea-pig isolated main bronchi due to electrical stimulation were concentration-dependently inhibited by [d-Met2, Pro5]-enkephalinamide (10 nM–1 μM). This effect was abolished by naloxone (1 μM). Naloxone alone induced no change in the stimulation-evoked contractions of the bronchus, indicating that no endogenous opioid control was present. Substance P and neurokinin A induced bronchial contractions that were not influenced by [d-Met2, Pro5]-enkephalinamide. This indicates that [d-Met2, Pro5]-enkephalinamide inhibits electrically-evoked bronchial contractions by reduced mediator release from capsaicin-sensitive sensory nerve endings, since these contractions are most probably brought about by tachykinins, released from afferent neurones. Capsaicin-induced bronchial contractions were in contrast to electrical stimulation not influenced by [d-Met2, Pro5]-enkephalinamide which suggests a different site of action. The activation of sensory neurones in the rabbit ear by i. a. injection of acetylcholine and capsaicin was not reduced under infusion of [d-Met2, Pro5]-enkephalinamide (1 and 10 μM) or lofentanil (1 and 10 μM). The enhancement of the effect of acetylcholine by infusion of prostaglandin E2 (0.15 μM) also remained unchanged under infusion of 10 μM [d-Met2, Pro5]-enkephalinamide. A peripheral analgesic action of the two opioid agonists studied is therefore not indicated.Keywords
This publication has 36 references indexed in Scilit:
- Opioid control of the function of primary afferent substance P fibresEuropean Journal of Pharmacology, 1985
- Prodynorphin opioid peptides in small somatosensory primary afferents of guinea pigNeuroscience Letters, 1985
- Morphine inhibits substance P release from peripheral sensory nerve endingsActa Physiologica Scandinavica, 1983
- Bronchial smooth muscle contraction induced by stimulation of capsaicin‐sensitive sensory neuronsActa Physiologica Scandinavica, 1982
- Inhibition of neurogenic vasodilatation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamideEuropean Journal of Pharmacology, 1982
- Peripheral antinociceptive effects of N-methyl morphineLife Sciences, 1982
- Analgesic effect of antagonists of substance PBiochemical and Biophysical Research Communications, 1981
- The in vitro pharmacology of D-Met2, Pro5-enkephalinamideJournal of Pharmacy and Pharmacology, 1981
- Opiate agonists inhibit neurogenic plasma extravasation in the ratEuropean Journal of Pharmacology, 1981
- Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivoNature, 1980